Psychedelics

'Largest' psilocybin access and data campaign intended to forward mission of promoting fungi-assisted psychotherapy

Cohen Foundation proudly supports organization dedicated to aiding underserved communities

Initial dose of FT-104 given in Adelaide, company announces name change

Canadian company continues to develop its presence in the clinical psychedelic sector

Clinical psychedelic sector value anticipated to ascend significantly into 2028

The drop was due to a shift in Numinus Bioscience operations

Psychedelic Fundamentals course to provide broad overview of a vast topic

FDA-approved psilocin study in California said to be first of its kind for industry

Married couple now run state-of-the-art laboratory in Las Vegas dedicated to advancing new therapies

Canadian life sciences outfit continues to push the envelope in the clinical psychedelic sector

Company stock portfolio appreciates significantly since January 2021

Christie's helps psychedelic research group generate unprecedented revenue via crypto-asset art auction

Company announces development of novel intranasal formulation with promising efficacy

Patient enlistment for new study to treat Major Depressive Disorder set to begin promptly

B.C. Mental health care company develops passion inspired by Utah pioneers

Biotechnology outfit set to receive attention on American TV this summer

Company isolates 4-PO-Psilocin into biologically active salt with 99% purity ratio

Multi-organization psychedelic partnership set to launch on June 23

Novamind's clinics in Utah and Arizona will continue to operate as their current brand until later this year

Dimethyltryptamine continues to demonstrate tremendous therapeutic potential

Meeting for Vancouver Island growers and community leaders to be held on June 16.

Green Stripe was one of the first cannabis companies to get established in Jamaica

As rates of mental health disorders increase the demand for psychedelic treatments do too

The mushrooms will be grown and distributed from Optimi's 20,000 square foot EU-GMP facility in Princeton

The shrooms will be supplied to Halucenex in the form of whole, dried mushroom fruiting bodies

The aim is to expand the evidence base on psilocybin-assisted psychotherapy to inform practical policies and regulations

Current shareholders of the firm will receive shares of each company

Series of concerts across the U.S. and Canada will explore music’s role in psychedelic-assisted therapy

The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds

The transaction is expected to close around June

But whether or not the disruption helps with the substance's antidepressant properties still needs further research

Lawmakers note that current therapeutic trials for substance use issues exclude people with a history of substance abuse

Previous experience was rated more important than shared symptoms, gender or ethnicity

The firm owns rights to a treatment protocol used at a popular clinic in Cancun, Mexico

CEO Payton Nyquvest says the authorization moves his firm closer to developing medicines at scale to support psychedelic-assisted therapy

Mixing MDMA with heavier antidepressants can be fatal

Used in sacred traditions for centuries, the firm says research will bring their medicinal benefits to a larger audience

But there are some physiological differences between the two

The long-term benefits contrast with the more temporary effects of conventional antidepressants

Health Canada's guidance on how to access illicit substances for medical purposes has been a moving target over the past year